It is true that there are many questionable COVID-19 antibody tests currently available in the US market. The FDA recently launched a national investigation of antibody testing manufacturers, and is now requiring them to submit clinical testing data and receive an Emergency Use Authorization (EUA). The EUA process requires testing manufacturers meet sensitivity and specificity standards established by the FDA to ensure the quality of these tests. ZOOM+Care partners with a national reference lab, LabCorp, to support all of the COVID-19 testing conducted at our clinics. We are continually monitoring this testing platform to ensure our partners are meeting our rigorous quality standards and the expectations of our patients, clinicians, and the communities we serve.
Comments
0 comments
Please sign in to leave a comment.